We focus on kidney and breast cancer. We study tumor suppressors and oncogenes, as well as tumor cell microenvironment (especially hypoxia). We are interested in tumor cell metabolism and metastasis. Our ultimate goal is to find critical molecular targets expressed by cancer cells for therapy design.